Home
>
National Drug Code (NDC)
>
Bisoprolol Fumarate and Hydrochlorothiazide
Bisoprolol Fumarate and Hydrochlorothiazide - 43063-134-30 - (bisoprolol fumarate and hydrochlorothiazide)
Drug Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Product NDC: | 43063-134 |
| Proprietary Name: | Bisoprolol Fumarate and Hydrochlorothiazide |
| Non Proprietary Name: | bisoprolol fumarate and hydrochlorothiazide |
| Active Ingredient(s): | 10; 6.25 mg/1; mg/1 & nbsp; bisoprolol fumarate and hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Product NDC: | 43063-134 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075768 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111003 |
Package Information of Bisoprolol Fumarate and Hydrochlorothiazide
| Package NDC: | 43063-134-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-134-30) |
NDC Information of Bisoprolol Fumarate and Hydrochlorothiazide
| NDC Code | 43063-134-30 |
| Proprietary Name | Bisoprolol Fumarate and Hydrochlorothiazide |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-134-30) |
| Product NDC | 43063-134 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bisoprolol fumarate and hydrochlorothiazide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20111003 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
| Strength Number | 10; 6.25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
